AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2015
Apr 10, 2015
3174_iss_2015-04-10_dbe286dc-5df0-4e46-a67b-5045af9c3ee8.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Altaris Capital Partners
Instrument
| Instrument | Shares SE0003613090 |
|---|---|
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 10/04/2015 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 0 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 0 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | |||
| paragraph, line 2 | Instruments - FITA Ch. 4, section 2, first Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Cash settled | - Physically settled | ||
| Total | |||
| Published | |||
| 10/04/2015 13:17 | |||
| Contact | |||
| Name | Fredrik Konopik | ||
| Phone | +46856628676 Email [email protected] |
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13